Navigation Links
New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
Date:3/6/2008

p>

Forward Looking Statements

This press release may include forward-looking statements. These forward-looking statements are based on current expectations about future events affecting us and are subject to uncertainties and factors, all of which are difficult to predict and many of which are beyond our control, including: risks related to our assumption that Masimo's new noninvasive measurements -- total hemoglobin (SpHb(TM)) and oxygen content (SpOC(TM)) -- will deliver a sufficient level of clinical improvement over alternative hemoglobin testing capabilities to allow for rapid adoption of the technology and risks related to our assumptions regarding the timing or commercial availability of SpHb and SpOC, and will be timely cleared, if ever, by appropriate regulatory bodies, as well as other factors discussed in the "Risk Factors" section of our annual report on Form 10-K for the year ended December 29, 2007, filed with the Securities and Exchange Commission on March 4, 2008. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We do not undertake any obligation to update, amend or clarify these forward-looking statements or the risk factors contained in our annual report on Form 10-K for the year ended December 29, 2007, whether as a result of new information, future events or otherwise, except as may be required under the federal securities laws.

(1) Continuous Noninvasive Measurement of Hemoglobin via Pulse

CO-Oximetry. Mark R. Macknet, Penny L. Kimball-Jones, Richard L.

Applegate, Robert D. Martin, Martin W. Allard. Anesthesiology, Loma

Linda University, Loma Linda, CA.

(2) Casual Screening of Hemoglobin Noninvasively Positively Affects a

Colleague's Future. Mart
'/>"/>

SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
2. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
3. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
4. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
5. EDICT Opens Public Comment Period for Clinical Trials Policy Recommendations
6. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
7. Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone)
8. NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP
9. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
10. Treatment of First Patient in Phase I Clinical Trial of Bionomics Anti-Cancer Drug BNC105
11. Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCall...ced results for its first quarter ended September ...er diluted share, on revenues of $3,263,000. This...r diluted share, on revenues of $3,168,000 for the...he first quarter results, Biotel President and CEO...
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire...(NYSE: BDX ) today announced the completion of i...chigan-based company that develops and manufacture...orms. ,, In May 2009, BD and HandyLab announced...ercialize molecular assays on the HandyLab Jaguar(...
(Date:11/19/2009)..., , ARDEE, Ireland, Nov. 19 ...ed the pricing of its previously announced seconda...t a price to the public of $22.25 per share. The ... Bain Capital Partners, DLJ Merchant Banking, J.P....mas H. Lee Partners, L.P., certain other instituti...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 1Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 2Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 3Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 4Frost 26 Sullivan Recognizes Cisbio Bioassays for Technology Innovation 12546 5Alcohol advertising self regulation not working as ads target younger drinkers 48311 1Alcohol advertising self regulation not working as ads target younger drinkers 48311 2Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 1Researchers estimate risk of transmission of Huntingtons disease to offspring among male carriers 48309 2
...uticals, Inc.,announced today that a new analysis ... Biomedical Research Institute at Harbor-UCLA Medi...of hypogonadal men with AndroGel(R),(testosterone ...rdless of,weight and body mass index (BMI). These ...ocrine Society Annual Meeting (ENDO) in San Franci...
...ONE MINERAL DENSITY, SAN DIEGO, June 17 Neurocri...ay that the elagolix 0603 Phase IIb trial,(Petal S...he last subject,completed her Week 24 study visit ...mpact of elagolix treatment on bone mineral densit...X-ray Absorptiometry (DXA) scans to,document any c...
Other Medicine Technology:New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 2New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 3New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 4Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 2Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis 3
(Date:11/23/2009)...E,Tenn.,Nov.23/PRNewswire/--HealthLeaders-InterStu...,reportsthatself-insuredmembercompaniesthatarepart...danaggregatehealthcare-costdecreaseof1.5percentper...ninahigh-performanceprovidernetwork.Accordingtothe...lf-insuredmembercompaniessaved$44millioninhealthca...
(Date:11/23/2009)...HOOT15MILLIONFREETHROWSIN2010WORLD,SLARGESTFREETHR....S.TOUR&TRIPTOAFRICANEXTYEAR ,, WORLDVISI...,, SEATTLE,Nov.23/PRNewswire-USNewswire/--Nextw...usandsnationwidewilltakepartin HoopsofHope ,thewor...hemovementis15-year-old AustinGutwein fromMesa,Ari...
(Date:11/23/2009)....23/PRNewswire-FirstCall/-- ,, DearIsisSupporte...ngyouforyourcontinuingsupportofIsis.Webelieveweare...rulyattheendofthebeginningofcreatingauniquecompany...essesmanyoftheissueshauntingthepharmaceuticalindus...ccessofourflagshipdrug,mipomersen.Mipomersencontin...
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/--NewCardio,Inc.,(OTCBu...der,announcedtodaythatCEO,Dr.BranislavVajdic,andCF...ROConferenceonThursday,December3rd,at4:30PMPSTatth...entwillbeavailableforone-on-onemeetingsonWednesday...rettAimeeMaasat(646)536-7331or brett@haydenir.com ...
(Date:11/23/2009)...swire/--TheBerylCompanies,thenation,sleadingprovid...dustry,hasearnedrecognitionasoneofthetopoutsourcin...,sleadingtrademagazine.Berylwasrankedamongthepubli...inessresults,whichenabledittoclimbfromtwelfthplace...htoitsinnovativeproducts,suchasitsnewestlaunchofpo...
Breaking Medicine News(10 mins):Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 3Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2
...nis Giesing, Chief Scientific,Officer and Terry Ni...als,Inc. (OTC Bulletin Board: URGP) (http://www.u...view with http://www.wallst.net scheduled for No...ncluding Urigen Pharmaceutical,s,market potential,...
...spinal damage most common reasons for ER visits, s...y News) -- While riding an all-terrain vehicle (AT...o often it can end in a serious injury and a trip ...t the most common injuries that youngsters sustain...
... 2007) Rutgers College of Nursing faculty member ... of the Rutgers-Newark Provosts Award for Communit...ch of broad scholarly significance based in whole ...ement to acknowledge the valuable relationships Ru...
...p Global Health,Inc. (OTC Bulletin Board: FGHH) wi... November 29, 2007. Mr. Fred Nazem, Chairman, and ...will host the investor call and will be,giving a d...s toll free, (866) 566-1240 (domestic) and (702),4...
...ology allows medical professionals to instantly ..., WESTCHESTER, Ill., Nov. 26 BrainLAB, a global ...ss-invasive medical treatments,today showcased one...of a traditional hospital lightbox with the,featur...
...26 American,Physicians Capital, Inc. (Nasdaq: AC...d its $15 million authorization approved by its Bo...ionary stock repurchase program,which had approxim...ts Board of Directors on August 16, 2007., "I am ...
Other Medicine News:Health News:WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals 2Health News:ATV Injuries on the Rise 2Health News:ATV Injuries on the Rise 3Health News:Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award 2Health News:Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment 2Health News:Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment 3Health News:American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program 2Health News:American Physicians Capital, Inc. Completes $15 Million Authorization and Commences $20 Million Authorization Under Stock Repurchase Program 3
Lambda Fluoro 320
DELFIA Platewash
SkanStacker (110V)
...he Labcyte miniGene LW is a new plate washing syst...96 and 384 channel microplates with flat, V-shaped...with 8 or 16 channel nozzle heads. Simple LCD touc...ional plate stacker is available for the miniGene ...
Medicine Products: